{"prompt": "['2017N331008_0', 'CONFIDENTIAL', '208090', \"All deviations need to be documented in the participant's source records and placed in a\", 'dedicated COVID-19 folder. The site should continue to manage and submit protocol', 'deviations per local requirements.', '11.14.5.2. Capturing COVID-19 Specific AEs and SAEs', 'It is important for the study team to describe COVID-19 related adverse events/serious', 'adverse and their impact on study data and outcomes. Standardization of case definitions', 'will facilitate future data analysis.', 'Please use the following guidance:', '1.', 'AEs should continue to be evaluated as to whether they meet SAE criteria as', 'defined in the protocol, and if so, submitted according to established SAE', 'reporting requirements. SAEs and AEs should be submitted following usual study', 'procedures and timelines.', '2.', 'When an in-person clinic visit is not possible, please conduct a remote telehealth', 'visit to assess for, and document any AEs/SAEs.', '3.', 'Investigators should use the WHO definition to classify COVID-19 cases. The', 'definition below, released March 20, 2020, represents a time point for', 'standardized collection. We recognize definitions are likely to continue to evolve.', 'When reporting both serious and non- serious adverse events (related to COVID-', '19 infection), investigators should use the following Verbatim terms:', 'a) Suspected COVID-19 infection; or', 'b) Probable COVID-19 infection; or', 'c) Confirmed COVID-19 infection', '4.', 'Sites should contact the study Medical Monitor for questions related to definitions', 'and reporting, and decisions around impact to study drug continuation.', '5.', 'A new COVID-19 infection Case Report Form will be added to the eCRF to', 'collect additional details about the reported COVID-19 AE or SAE data. It is', 'important to collect the correct information from each participant reporting a', 'COVID-19 AE or SAE. Therefore, please use the CRF templates to help you', 'collect this information for all COVID-19 related AEs/SAEs, once available.', '161']['2017N331008_06', 'CONFIDENTIAL', '208090', 'WHO Case Definition (March 20, 2020 Version) (https://www.who.int/publications-', 'detail/global-surveillance-for-human-infection-with-novel-coronavirus-(2019-ncov)):', 'Suspected case:', 'A. A patient with acute respiratory illness (fever and at least one sign/symptom of', 'respiratory disease, e.g., cough, shortness of breath), AND a history of travel to or', 'residence in a location reporting community transmission of COVID-19 disease', 'during the 14 days prior to symptom onset;', 'OR', 'B. A patient with any acute respiratory illness AND in contact (see definition of', '\"contact\" below) with a confirmed or probable COVID-19 case (see definition of', 'contact) in the last 14 days prior to symptom onset;', 'OR', 'C. A patient with severe acute respiratory illness (fever and at least one', 'sign/symptom of respiratory disease, e.g., cough, shortness of breath; AND', 'requiring hospitalization) AND in the absence of an alternative diagnosis that', 'fully explains the clinical presentation.', 'Probable case:', 'A. A suspect case for whom testing for the COVID-19 virus is inconclusive', '(Inconclusive being the result of the test reported by the laboratory).', 'OR', 'B. A suspect case for whom testing could not be performed for any reason.', 'Confirmed case:', 'A person with laboratory confirmation of COVID-19 infection, irrespective of clinical', 'signs and symptoms.', 'Covid-19 Contact:', 'A contact is a person who experienced any one of the following exposures during the 2', 'days before and the 14 days after the onset of symptoms of a probable or confirmed case:', '1. Face-to-face contact with a probable or confirmed case within 1 meter and for', 'more than 15 minutes;', '2. Direct physical contact with a probable or confirmed case;', '3. Direct care for a patient with probable or confirmed COVID-19 disease without', 'using proper personal protective equipment; OR', '4. Other situations as indicated by local risk assessments.', '162']\n\n###\n\n", "completion": "END"}